Quest Diagnostics Inc (NYSE:DGX)
$ 153.02 0 (0%) Market Cap: 17.08 Bil Enterprise Value: 23.40 Bil PE Ratio: 20.57 PB Ratio: 2.52 GF Score: 86/100

Quest Diagnostics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 02:15PM GMT
Release Date Price: $114.55 (+0.85%)
Rivka Regina Goldwasser;Stephen H. Rusckowski
Morgan Stanley, Research Division - MD;Quest Diagnostics Incorporated - Chairman, President & CEO<

Thanks for joining us this morning in Day 3 of Morgan Stanley's Global Healthcare Conference. My name is Ricky Goldwasser. I'm Morgan Stanley's health care services analyst. And before we get started, please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley's employees only. It's not for member of the press. So if you are a member of the press, please disconnect and reach out separately. For important disclosures, please see Morgan Stanley's Research Disclosure website at www.morganstanley.com. And if you have any questions, please reach out to your Morgan Stanley sales representative.

And with that, I'm very pleased to have the Quest Diagnostics team on with us. We have CEO, Steve Rusckowski; EVP of Operations, Jim Davis; and Head of IR, Shawn Bevec.

So Steve, Jim and Shawn, welcome to our conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot